Replies to post #99983 on Biotech Values

[genisi]

Guess AF listened to Norbert Bischofberger too :)
The virologic failure rate difference was higher in ECHO trial (11.0% vs 4.4%) than in THRIVE (7.1% vs 5.3%), and there's no explanation for this either.